refractory metastatic prostate cancer research hub

A Single-Dose Two-Period Crossover Study to Assess the Effect of Food on MK-5684 Pharmacokinetics and to Monitor Pharmacodynamic Effects Over Time in Healthy Participants

This study looks at how a new medicine, MK-5684, behaves in healthy men when taken with or without food. It also checks how the medicine affects certain hormone levels over time. This early research helps scientists understand the drug before testing it in patients with advanced prostate cancer.